Cognitive Impairment Associated With Schizophrenia (CIAS) Market is segmented By Drug Class (Cognitive Enhancers, NMDA Receptor Antagonists, Antipsychotic Medications), By Indication (Schizophrenia with Cognitive Impairment, Bipolar Disorder with Cognitive Impairment, Major Depressive Disorder with Cognitive Impairment), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned.